Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

24.44
-0.7900-3.13%
Post-market: 24.540.1000+0.41%19:30 EDT
Volume:1.04M
Turnover:25.52M
Market Cap:3.11B
PE:-6.32
High:25.58
Open:25.48
Low:24.09
Close:25.23
52wk High:31.74
52wk Low:13.21
Shares:127.33M
Float Shares:89.84M
Volume Ratio:0.75
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8641
EPS(LYR):-3.2900
ROE:-90.82%
ROA:-30.39%
PB:6.71
PE(LYR):-7.43

Loading ...

Arcus Biosciences (RCUS) Dropped, What Is Behind The Latest Attention?

Simply Wall St.
·
Yesterday

Arcus Biosciences Price Target Maintained with a $43.00/Share by Wedbush

Dow Jones
·
Sep 30

Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME)

TIPRANKS
·
Sep 25

Arcus Biosciences Grants New-Hire Stock Options for 21,200 Shares at $26.39 Per Share

Reuters
·
Sep 25

Arcus Biosciences to Present New ARC-20 Casdatifan Data in Kidney Cancer at Oct. 20 Investor Event

Reuters
·
Sep 22

Arcus Biosciences Initiated at Buy by TD Cowen

Dow Jones
·
Sep 16

U.S. Stocks on the MOVE-Intel, Axon Enterprise, J.B. Hunt

Reuters
·
Sep 16

Arcus Gains After TD Cowen Starts Coverage with 'buy' Rating

Reuters
·
Sep 16

TD Cowen Initiates Arcus Biosciences at Buy

MT Newswires Live
·
Sep 16

Arcus Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
Sep 16

U.S. Research Roundup-Domino's, McDonald's, Starbucks

Reuters
·
Sep 16

Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

TIPRANKS
·
Sep 10

Arcus Biosciences Grants New Hire Options for 26,350 Shares, RSUs for 13,200 Shares

Reuters
·
Sep 10

Arcus Biosciences Price Target Raised to $40.00/Share from $35.00 by Truist Securities

Dow Jones
·
Sep 09

Arcus Biosciences, Inc. : Truist Securities Raises Target Price to $40 from $35

THOMSON REUTERS
·
Sep 08

Arcus Biosciences to Present at Citi 2026 Biotech Back to School Conference

Reuters
·
Aug 27

Arcus Biosciences Chief Accounting Officer Alexander Azoy Sells 2,827 Shares for $84,810

Reuters
·
Aug 25

What Arcus Biosciences (RCUS)'s Steep Revenue Drop and 2026 Guidance Cut Means For Shareholders

Simply Wall St.
·
Aug 16

Arcus Biosciences Memberi Hibah Induksi: Opsi 2.850 Saham Dan 1.450 RSU Untuk Karyawan Baru

Reuters
·
Aug 12

Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says

MT Newswires Live
·
Aug 11